These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 21664042

  • 41. Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype.
    Rio-Machin A, Ferreira BI, Henry T, Gómez-López G, Agirre X, Alvarez S, Rodriguez-Perales S, Prosper F, Calasanz MJ, Martínez J, Fonseca R, Cigudosa JC.
    Leukemia; 2013 Apr; 27(4):925-31. PubMed ID: 23174883
    [Abstract] [Full Text] [Related]

  • 42. Study on the Association Between miRNA-202 Expression and Drug Sensitivity in Multiple Myeloma Cells.
    Shen X, Guo Y, Qi J, Shi W, Wu X, Ni H, Ju S.
    Pathol Oncol Res; 2016 Jul; 22(3):531-9. PubMed ID: 26689580
    [Abstract] [Full Text] [Related]

  • 43. [Expression level of microRNA-92a and its clinical significance in multiple myeloma patients].
    Qu XY, Zhang SS, Wu S, Hong M, Li JY, Chen LJ, Xu JR.
    Zhonghua Xue Ye Xue Za Zhi; 2013 Apr; 34(4):332-6. PubMed ID: 23668207
    [Abstract] [Full Text] [Related]

  • 44. [Advances in the studies of miRNAs and cell apoptosis].
    Guo L, Ding ZH.
    Sheng Li Ke Xue Jin Zhan; 2007 Oct; 38(4):331-5. PubMed ID: 18232304
    [Abstract] [Full Text] [Related]

  • 45. A microRNA polycistron as a potential human oncogene.
    He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM.
    Nature; 2005 Jun 09; 435(7043):828-33. PubMed ID: 15944707
    [Abstract] [Full Text] [Related]

  • 46. Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma.
    Li F, Hao M, Feng X, Zang M, Qin Y, Yi S, Li Z, Xu Y, Zhou L, Sui W, Deng S, Zou D, Zhan F, Qiu L.
    Leuk Res; 2015 Jul 09; 39(7):793-9. PubMed ID: 25975752
    [Abstract] [Full Text] [Related]

  • 47. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis.
    Pichiorri F, Suh SS, Ladetto M, Kuehl M, Palumbo T, Drandi D, Taccioli C, Zanesi N, Alder H, Hagan JP, Munker R, Volinia S, Boccadoro M, Garzon R, Palumbo A, Aqeilan RI, Croce CM.
    Proc Natl Acad Sci U S A; 2008 Sep 02; 105(35):12885-90. PubMed ID: 18728182
    [Abstract] [Full Text] [Related]

  • 48. MicroRNA-1271 inhibits proliferation and promotes apoptosis of multiple myeloma cells through inhibiting smoothened-mediated Hedgehog signaling pathway.
    Xu Z, Huang C, Hao D.
    Oncol Rep; 2017 Feb 02; 37(2):1261-1269. PubMed ID: 27959416
    [Abstract] [Full Text] [Related]

  • 49. MiR-15a/16 regulates the growth of myeloma cells, angiogenesis and antitumor immunity by inhibiting Bcl-2, VEGF-A and IL-17 expression in multiple myeloma.
    Li Y, Zhang B, Li W, Wang L, Yan Z, Li H, Yao Y, Yao R, Xu K, Li Z.
    Leuk Res; 2016 Oct 02; 49():73-9. PubMed ID: 27596960
    [Abstract] [Full Text] [Related]

  • 50. MicroRNAs as regulators and mediators of c-MYC function.
    Jackstadt R, Hermeking H.
    Biochim Biophys Acta; 2015 May 02; 1849(5):544-53. PubMed ID: 24727092
    [Abstract] [Full Text] [Related]

  • 51. Increased expression of miR-27 predicts poor prognosis and promotes tumorigenesis in human multiple myeloma.
    Che F, Wan C, Dai J, Chen J.
    Biosci Rep; 2019 Apr 30; 39(4):. PubMed ID: 30837325
    [Abstract] [Full Text] [Related]

  • 52. miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer.
    Tsuchida A, Ohno S, Wu W, Borjigin N, Fujita K, Aoki T, Ueda S, Takanashi M, Kuroda M.
    Cancer Sci; 2011 Dec 30; 102(12):2264-71. PubMed ID: 21883694
    [Abstract] [Full Text] [Related]

  • 53. MiRNA-29a as a tumor suppressor mediates PRIMA-1Met-induced anti-myeloma activity by targeting c-Myc.
    Saha MN, Abdi J, Yang Y, Chang H.
    Oncotarget; 2016 Feb 09; 7(6):7149-60. PubMed ID: 26771839
    [Abstract] [Full Text] [Related]

  • 54. Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma.
    Hao M, Zang M, Wendlandt E, Xu Y, An G, Gong D, Li F, Qi F, Zhang Y, Yang Y, Zhan F, Qiu L.
    Int J Cancer; 2015 Apr 15; 136(8):1835-44. PubMed ID: 25220540
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. The transcription factor c-Myc suppresses MiR-23b and MiR-27b transcription during fetal distress and increases the sensitivity of neurons to hypoxia-induced apoptosis.
    Chen Q, Zhang F, Wang Y, Liu Z, Sun A, Zen K, Zhang CY, Zhang Q.
    PLoS One; 2015 Apr 15; 10(3):e0120217. PubMed ID: 25781629
    [Abstract] [Full Text] [Related]

  • 57. miR-183 as a molecular and protective biomarker for cancer in schizophrenic subjects.
    Rizos E, Siafakas N, Koumarianou A, Katsantoni E, Filippopoulou A, Ntounas P, Touloumis Ch, Kastania A, Zoumpourlis V.
    Oncol Rep; 2012 Dec 15; 28(6):2200-4. PubMed ID: 23007659
    [Abstract] [Full Text] [Related]

  • 58. Seed targeting with tiny anti-miR-155 inhibits malignant progression of multiple myeloma cells.
    Feng M, Luo X, Gu C, Fei J.
    J Drug Target; 2015 Jan 15; 23(1):59-66. PubMed ID: 25185784
    [Abstract] [Full Text] [Related]

  • 59. Selective activation of miRNAs of the primate-specific chromosome 19 miRNA cluster (C19MC) in cancer and stem cells and possible contribution to regulation of apoptosis.
    Nguyen PN, Huang CJ, Sugii S, Cheong SK, Choo KB.
    J Biomed Sci; 2017 Mar 07; 24(1):20. PubMed ID: 28270145
    [Abstract] [Full Text] [Related]

  • 60. Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1.
    Zhang YK, Wang H, Leng Y, Li ZL, Yang YF, Xiao FJ, Li QF, Chen XQ, Wang LS.
    Biochem Biophys Res Commun; 2011 Oct 14; 414(1):233-9. PubMed ID: 21951844
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.